Leukemia ASH 2022: Impact of Momelotinib on Patient-Reported Quality of Life for Patients With Myelofibrosis
Leukemia ASCO 2022: What Factors May Contribute to Asparaginase-Associated Toxicities During ALL Induction Therapy?
